Company logo

BNTX - BioNTech SE

NASDAQ -> Healthcare -> Biotechnology
Mainz, Germany
Type: Equity

BNTX price evolution
BNTX
(in millions $) 6 Nov 2023 7 Aug 2023 30 Jul 2023 27 Mar 2023
Current assets
Cash $13943.45 $15038.35 $14166.6 $14533.37
Short term investments $2929.65 $2059.91 $483.6
Net receivables $2068.41 $2821.45 $2995.4 $7484.6
Inventory $429.49 $476.52 $448.9 $460.46
Total current assets $19371 $20396.23 $19213.9 $22962.03
Long term investments $3572.8 $3197.03 $1421.48
Property, plant & equipment $753.08 $733.63 $894 $638.1
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $22943.8 $23593.26 $22225.6 $24383.51
Current liabilities
Accounts payable $230.09 $242.67 $228.6 $213.78
Deferred revenue
Short long term debt $41.33 $40.98 $37.71
Total current liabilities $1867.14 $1930.93 $1819 $3090.58
Long term debt $167.27 $177.38 $167.1 $184.56
Total noncurrent liabilities
Total debt
Total liabilities $2418.03 $2461.81 $2319.1 $3376.43
Shareholders' equity
Retained earnings $19945.75 $20322.88 $19666.7 $19726.48
Other shareholder equity
Total shareholder equity $20525.77 $21131.45 $21007.08
(in millions $) 31 Jan 2023 30 Mar 2022 30 Dec 2020 30 Dec 2019
Current assets
Cash $13875.1 $1715.46 $1210.21 $519.15
Short term investments $483.6 $502.06 $137.23 $1.68
Net receivables $7146 $12548.2 $166.37 $20.2
Inventory $439.6 $509.26 $64.12 $12.07
Total current assets $21922 $15274.98 $1666.9 $560.15
Long term investments $1421.48 $768.7
Property, plant & equipment $821.1 $326.84 $325.96 $148.06
Goodwill & intangible assets
Total noncurrent assets $744.46 $266
Total investments
Total assets $23279.1 $16043.68 $2318.62 $797.65
Current liabilities
Accounts payable $204.1 $162.15 $102.29 $20.5
Deferred revenue
Short long term debt $37.71 $131.65 $3.02 $1.82
Total current liabilities $2950.6 $3528.42 $606.01 $138.14
Long term debt $176.2 $173.91 $153.02 $14.78
Total noncurrent liabilities $389.25 $185.93
Total debt $293.41 $83.24
Total liabilities $3223.5 $3990.04 $946.77 $304.15
Shareholders' equity
Retained earnings $19812.3 $10015.8 -$409.63 -$424.83
Other shareholder equity $1768.3 $1539.95 $691.54
Total shareholder equity $21007.08 $12053.64 $1371.85 $493.49
(in millions $) 6 Nov 2023 7 Aug 2023 30 Jul 2023 27 Mar 2023
Revenue
Total revenue $925 $178.02 $167.7 $4609.67
Cost of revenue $167.17 $172.92 $225.9
Gross Profit $757.83 $5.1 $4.8 $4383.77
Operating activities
Research & development $514.42 $396.38 $563.47
Selling, general & administrative $164.17 $149.46 $157.43
Total operating expenses $845.75 $718.77 $509.5 $776.56
Operating income $79.24 -$540.75 $3833.11
Income from continuing operations
EBIT $79.24 -$540.75 $2668.77
Income tax expense $69.02 -$235.45 -$221.8 $957.33
Interest expense $93.8
Net income
Net income $165.93 -$202.12 -$190.4 $2436.21
Income (for common shares) $165.93 -$202.12 $2436.21
(in millions $) 27 Mar 2023 31 Jan 2022 30 Dec 2020 30 Dec 2019
Revenue
Total revenue $18131.85 $482.32 $108.59
Cost of revenue $3137.09 $704.36 $243.83
Gross Profit $14994.76 -$222.04 -$135.24
Operating activities
Research & development $1609.92
Selling, general & administrative $570.02 $107.22 $48.8
Total operating expenses $5743.34 $808.13 $290.11
Operating income $12388.52 -$325.8 -$181.52
Income from continuing operations
EBIT $12388.52 -$325.8 -$181.52
Income tax expense $3686.68 -$161 -$0.27
Interest expense -$2 -$1.72
Net income
Net income $9881.99 $15.2 -$179.06
Income (for common shares) $9881.99 $15.2 -$179.06
(in millions $) 6 Nov 2023 7 Aug 2023 30 Jul 2023 27 Mar 2023
Net income $165.93 -$202.12 $2436.21
Operating activities
Depreciation $40.87 $33.76 $38.91
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $732.89 $4658.79 $2022.56
Investing activities
Capital expenditures -$145.06 -$328.16 -$171.16
Investments
Total cash flows from investing -$1187.2 -$2430.49 -$3027.2 -$157.26
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$16664.5 -$16879.9 -$14794.7
Total cash flows from financing -$308.42 -$172.53 -$454.7 -$190.39
Effect of exchange rate $64.1
Change in cash and equivalents $13943.45 $15038.35 $291.5 $14533.37
(in millions $) 27 Mar 2023 30 Mar 2022 30 Dec 2020 30 Dec 2019
Net income $9881.99 $10477.47 $15.2 -$179.06
Operating activities
Depreciation $129.15 $76.55 $38.74 $33.9
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $14221.54 $905.69 -$13.47 -$198.54
Investing activities
Capital expenditures -$380.54 -$156.77 -$66.03 -$38.59
Investments
Total cash flows from investing -$36.97 -$576.27 -$144.85 -$77.11
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$14794.7 -$1920.51 $141.72 $7.94
Total cash flows from financing -$1486.63 $95.89 $894.73 $383.29
Effect of exchange rate -$45.34 $0.02
Change in cash and equivalents $12663.78 $384.53 $691.06 $107.65
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $5.88B
EBITDA N/A
EBIT N/A
Net Income $2.21B
Revenue Q/Q -72.07%
Revenue Y/Y -60.50%
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA 9.49%
ROE N/A
Debt/Equity 0.15
Net debt/EBITDA N/A
Current ratio 10.37
Quick ratio 10.14